Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > The Supervisory Council of the Russian Corporation of Nanotechnologies approved the project on establishing the first closed-end mutual fund

Abstract:
The partner for this project was selected by the Corporation among the leading Russian business schools. It is the Moscow Management School SKOLKOVO, which will raise the 1 billion rubles adding to the fund's chartered capital. The total fund amount will reach 2 billion rubles. The Managing Company of the fund will be Troyka Dialog.

The Supervisory Council of the Russian Corporation of Nanotechnologies approved the project on establishing the first closed-end mutual fund

MOSCOW, Russia | Posted on December 26th, 2008

From the opinion of the managing director, member of RUSNANO Board of Directors Dionis Gordin, the joint project of RUSNANO and SKOLKOVO is a striking example of melding the Corporation's educational and investment objectives: the trust activity will be directed towards discovery of the commercial potential of the Russian nanotechnologies, providing the trust investors with high return of their investments as well as improving the quality of training in the sphere of innovative management and building of the efficient practice within the business school framework.

- One of the problems with venture business today is that there is a gap between a business idea and its implementation in the investment project, says Dionis Gordin. - In average, less than 10% of the projects submitted to the venture trusts pass through the primary consideration stage. It happens due to low quality of the business plans, calculations, marketing researches, scientific and technical substantiation etc. The venture trust will involve the students and tutors of SKOLKOVO into business planning and pre-investment preparation of the most interesting projects submitted into the Fund.

- We value the advantages and perspectives opening for our students thanks to cooperation with the Russian Corporation of Nanotechnologies, emphasized Andrey Volkov, Head of Moscow Management School SKOLKOVO. - Program SKOLKOVO MBA which will be launched in 2009 implies the development of own business projects by students. The best projects will obtain venture financing. The criterion of the project selection is their innovative component. We are sure that our cooperation with RUSNANO will motivate them for creating truly advanced technologies beneficial not only for their authors but for our country as well.

####

About Russian Corporation of Nanotechnologies
Russian Corporation of Nanotechnologies (RUSNANO) was established in 2007 by the Federal law № 139-FZ to enable Government policy in the field of Nanotechnology.

To accomplish this task, the Corporation co-invests in nanoindustry projects with high commercial potential or social benefit. Early stage investment from the Corporation lowers the risk of its investment partners from the private sector.

The Corporation participates in building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds. The Corporation provides scientific and educational programs that are required for its investment projects to succeed, and also supports the popularization of nanoscience and nanotechnology. The Corporation selects projects for investment on the basis of longer-term foresights/predictions created by the leading Russian and world experts.
To assist the Russian nanoindustry advance to the global market and strengthening of its international links the Corporation develops partnerships with the leading nanotechnology centers in the world and organizes the annual Nanotechnology International Forum in Russia.

For more information, please click here

Contacts:
Russian Corporation of Nanotechnologies
Nametkina Street, 12A, Moscow, Russia 117420
Phone: +7 495 542 4444
Fax: +7 495 542 4434

Copyright © Russian Corporation of Nanotechnologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

Investments/IPO's/Splits

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Arrowhead to Present at Upcoming March Conferences March 1st, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic